• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION MAXZERO NEEDLELESS CONNECTOR; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION MAXZERO NEEDLELESS CONNECTOR; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number MZ1000-07
Device Problems Fluid/Blood Leak (1250); Obstruction of Flow (2423)
Patient Problems Low Blood Pressure/ Hypotension (1914); Therapeutic Response, Decreased (2271); No Code Available (3191)
Event Date 06/16/2018
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: central venous line; picc line.Therapy date (b)(6) 2018.No product will be returned per customer.The customer complaint could not be confirmed because the product was discarded and not returned for failure investigation.The root cause of this failure was not identified.(b)(4).
 
Event Description
The customer reported that the patient had a picc line and right internal jugular central venous line (rij cvl) that experienced occlusions and leaks.The picc line was noted to be leaking and required rewirement causing the nurse to suspect that the patient was not receiving the ordered inotropes.The picc lumen stopped working and the infusions of epinephrine at 0.03, calcium, milrinone, dexamethasone and fentanyl were switched to a different lumen with the occluded lumen eventually requiring administration of tpa.The patient experienced decreased pressures and required an increase in sedation boluses.It was later noted that the picc line presented with sluggish blood return with the pumps alarming occlusion/high pressure.The maxzero¿ valves were removed from the infusion lines and the issue was resolved.The rij cvl required re-suturing and rewiring due to leaking and had no further issues after the rewiring; however, it was later reported that the rij cvl required tpa due to sluggish blood return while continuing to flush easily.Heparin was infusing at a kvo rate to keep the line open.The rij cvl continued to leak with dressing changes and skin excoriation noted under the dressing and eventually was discontinued due to the leaking and excoriation.The customer alleges that the maxzero¿ valve was not working correctly and was causing the line occlusions and leaks.There was no report of lasting harm caused to the patient.Based on information currently available, the reported leaks appear to all be around the catheter insertion site(s) with no apparent leaking from a bd product.
 
Event Description
The customer reported that the patient had a picc line and right internal jugular central venous line (rij cvl) that experienced occlusions and leaks.The picc line was noted to be leaking and required rewirement causing the nurse to suspect that the patient was not receiving the ordered inotropes.The picc lumen stopped working and the infusions of epinephrine at 0.03, calcium, milrinone, dexamethasone and fentanyl were switched to a different lumen with the occluded lumen eventually requiring administration of tpa.The patient experienced decreased pressures and required an increase in sedation boluses.It was later noted that the picc line presented with sluggish blood return with the pumps alarming occlusion/high pressure.The maxzero valves were removed from the infusion lines and the issue was resolved.The rij cvl required re-suturing and rewiring due to leaking and had no further issues after the rewiring, however, it was later reported that the rij cvl required tpa due to sluggish blood return while continuing to flush easily.Heparin was infusing at a kvo rate to keep the line open.The rij cvl continued to leak with dressing changes and skin excoriation noted under the dressing and eventually was discontinued due to the leaking and excoriation.The customer alleges that the maxzero valve was not working correctly and was causing the line occlusions and leaks.There was no report of lasting harm caused to the patient.Based on information currently available, the reported leaks appear to all be around the catheter insertion site(s) with no apparent leaking from a bd product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MAXZERO NEEDLELESS CONNECTOR
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key7881086
MDR Text Key120416203
Report Number9616066-2018-01692
Device Sequence Number1
Product Code FPA
UDI-Device Identifier10885403230196
UDI-Public10885403230196
Combination Product (y/n)N
PMA/PMN Number
K132413
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 08/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMZ1000-07
Device Catalogue NumberMZ1000-07
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/17/2018
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received10/30/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
(9) MZ9267,(6) MZ1000-07, SYRINGE, TD (B)(6) 2018; (9) MZ9267,(6) MZ1000-07, SYRINGE, TD (B)(6) 2018
Patient Outcome(s) Other; Required Intervention;
Patient Age2 MO
Patient Weight3
-
-